Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Investment Managers Series Trus (IREX)

2026-10-15T15:17:05.767982+00:00

Key Updates

IREX posted a +14.65% move since the last report, a technical bounce from the intraday low near $5.36 to the current $6.14. However, this recovery must be read in context: the 1-day change remains -14.18% versus the prior close of approximately $7.15, confirming that the rebound occurred entirely within a session already deep in negative territory rather than representing a reversal of trend. No company-specific news was identified for IREX during this period; all available news relates to the broader leveraged/inverse ETF industry (new product launches, a competitor liquidation event, and dealer activity in ETF swaps), which provides indirect context for the structural risk profile of products in this category.

Current Trend

The trust remains in a severe, multi-week collapse. YTD performance stands at -79.76% and the 6-month decline is -82.07%, with the 1-month figure at -56.33% and the 5-day figure at -38.67%. Reconstructing recent closes from the reported percentage changes implies a price path of roughly $34 (6m ago) → $14 (1m ago) → $10 (5d ago) → $7.15 (prior session close) → $6.14 (current), confirming an accelerating, not decelerating, downtrend punctuated by extreme intraday swings. The brief intraday bounce to $6.14 should be treated as a technical relief move within a dominant downtrend rather than a change in trajectory. Immediate resistance sits near the prior close of ~$7.15; support has not yet been established, as each prior "floor" has been breached within one to two sessions.

Investment Thesis

IREX exhibits the volatility signature of a leveraged or narrowly-targeted exposure vehicle rather than a diversified holding, consistent with the broader market context of leveraged/inverse single-stock and thematic ETFs referenced in recent industry news (e.g., Tradr's 2x products, Yorkville's MNGZ/MNGB). The investment case, if any, rests on short-term tactical positioning rather than fundamental value accumulation, given the magnitude and persistence of losses. No fundamental catalysts (earnings, asset flows, index changes) specific to IREX have been disclosed in the available data.

Thesis Status

The thesis of extreme, compounding-driven capital destruction remains intact and has not been invalidated by the latest bounce. The streak of consecutive double-digit losses (-5.83%, -10.01%, -10.62%, -10.63%, -16.12%) was briefly interrupted by a +14.65% intraday recovery, but the underlying 1-day reading of -14.18% confirms that volatility and downside pressure persist. The risk profile has not improved; if anything, the increasing frequency of large bidirectional swings (now including a sharp intraday reversal) signals deteriorating liquidity and price discovery, a pattern consistent with funds approaching distress or wind-down conditions as seen elsewhere in the leveraged ETF space.

Key Drivers

No direct fundamental news on IREX was published in the review period. Relevant indirect industry drivers include: Tradr's announced liquidation of five leveraged/inverse ETFs (CPNX, NXPX, PONX, SMZ, TSEU) effective October 19-26, 2026, illustrating that issuers are actively winding down underperforming leveraged products in the current environment (PR Newswire); continued new issuance of 2x leveraged products by Yorkville America (MNGZ launched September 17, 2026; MNGB launched September 21, 2026), both explicitly warning that investors "could lose all or substantially all invested capital in a single day" (PR Newswire, PR Newswire); and Jane Street's expansion into swaps tied to leveraged ETFs, signaling growing dealer participation and liquidity provision in this niche but structurally volatile product segment (Bloomberg).

Technical Analysis

Price action shows an intraday bounce of +14.65% from a low near $5.36 to $6.14, occurring within a session that still closed down -14.18% versus the prior day's $7.15 close. This pattern—a sharp rebound embedded within a net negative session—is characteristic of a market in capitulation, where short covering or bargain-hunting produces temporary spikes without altering the dominant trend. No established support level has held for more than one to two sessions over the past month; $7.15 now represents the nearest overhead resistance, while the current $6.14 level has no tested support below it given the absence of historical price stabilization in the available data.

Bull Case

  • Growing institutional dealer participation in leveraged ETF swaps (Jane Street, $1.2bn notional in Q2) indicates continued liquidity infrastructure supporting the broader leveraged ETF ecosystem in which IREX operates (Bloomberg)
  • Continued new product issuance in the leveraged/inverse space (MNGZ, MNGB) demonstrates active market demand and issuer confidence in the broader category, suggesting the underlying trading ecosystem remains functional despite individual fund distress (PR Newswire)
  • The +14.65% move since the last report indicates the presence of buy-side interest at lower price levels, potentially reflecting short-term tactical positioning or short covering
  • No further company-specific negative catalysts (e.g., liquidation announcement) have been disclosed for IREX, unlike peers such as CPNX, NXPX, PONX, SMZ and TSEU (PR Newswire)
  • Extreme oversold conditions following a seven-session streak of double-digit declines increase the statistical likelihood of near-term technical relief bounces

Bear Case

  • Direct industry precedent of ETF liquidations (Tradr shutting down CPNX, NXPX, PONX, SMZ, TSEU effective October 19-26, 2026) demonstrates that issuers actively wind down leveraged/inverse products suffering sustained losses, a material risk given IREX's comparable price collapse (PR Newswire)
  • YTD performance of -79.76% and 6-month decline of -82.07% confirm a prolonged, structural destruction of value rather than a transient dip
  • Leveraged product structures explicitly disclose the risk of losing "all or substantially all" value in a single day due to daily reset and compounding effects in volatile markets, a structural risk directly applicable to instruments exhibiting IREX's volatility profile (PR Newswire)
  • The reported +14.65% bounce occurred entirely within a session that still closed -14.18% lower day-over-day, indicating the rally lacks follow-through and genuine buying conviction
  • Seven consecutive sessions of double-digit percentage losses prior to this report indicate a broken market structure with no technical support level holding for more than one to two sessions
CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.